| Bioactivity | HBV-IN-35 (Compound 88) is a HBV inhibitor. HBV-IN-35 has anti-HBV activities in mouse and human hepatocytes (EC50: 100 nM and 400 nM respectively)[1]. |
| Name | HBV-IN-35 |
| Formula | C22H23F5N4O |
| Molar Mass | 454.44 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Hwang N, et al. Identification of novel tetrahydroquinoxaline derived phenyl ureas as modulators of the hepatitis B virus nucleocapsid assembly. Eur J Med Chem. 2023 Jul 17;259:115634. |